ArticleJournal of robotic surgery2021
Single-port robotic-assisted partial nephrectomy: initial clinical experience and lessons learned for successful outcomes.
Article in Journal of robotic surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Single-port versus multi-port robotic-assisted partial nephrectomy in perioperative, oncological, and renal function outcomes: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Systematic Review and Clinical Outcomes of new Robotic Systems in Urology.International braz j urol : official journal of the Brazilian Society of UrologyPooled it
- Safety and feasibility of reduced-port robotic distal gastrectomy for gastric cancer: a phase I/II clinical trial using the da Vinci Single Port(SP) robotic system.Scientific reports · 2023Trial
- Single-port robotic surgery for kidney and upper tract cancer: a narrative review.Translational andrology and urology · 2026Review
- Global research trends and hotspots in single-port robotic surgery in urology: a bibliometric analysis.Journal of robotic surgery · 2026Article
- Determinants of access route in single-port off-clamp robotic partial nephrectomy: A contemporary cohort study.Surgical endoscopy · 2026Article
- The current landscape of single-port robotic surgery in urology.Nature reviews. Urology · 2026Review
- Selective by design: early adoption patterns of single-port off-clamp robotic partial nephrectomy in a high-volume center.Journal of robotic surgery · 2025Article
- Single-port robotic surgery in gynecology: first experience in German-speaking countries using the Da Vinci SP system in benign andneoplastic diseases.Journal of robotic surgery · 2025Article
- Implementation and early outcomes of Da Vinci SP® Robot-Assisted partial nephrectomy via supine anterior retroperitoneal access: Italian single centre experience.Central European journal of urology · 2025Article
- Implementation of single-port robotic urologic surgery: experience at a large academic center.Journal of robotic surgery · 2024Article
- Early perioperative outcomes of single-port compared to multi-port robot-assisted laparoscopic partial nephrectomy.Journal of robotic surgery · 2023Article
- Perioperative and oncologic outcomes of single-port versus conventional robotic-assisted partial nephrectomy: an evidence-based analysis of comparative outcomes.Journal of robotic surgery · 2023Review
- Single-port versus multiport partial nephrectomy: a propensity-score-matched comparison of perioperative and short-term outcomes.Journal of robotic surgery · 2023Article
- Efficacy and safety of single port robotic radical prostatectomy and multiport robotic radical prostatectomy: a systematic review and meta-analysis.Translational andrology and urology · 2021Article
- A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer.Urologic oncology · 2021Review
- Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay.Therapeutic advances in urologyReview
- Robotic Single-Port Donor Nephrectomy with the da Vinci SP® Surgical System.JSLS : Journal of the Society of Laparoendoscopic SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Intuitive Surgical DaVinci SP ("Single Port") robotic platform was approved in 2014, but, recently, there has been a dissemination of the technology with multiple urological procedures successfully adapted to this robot. There are some important differences from prior models. We aimed to share our early outcomes and lessons learned for performing successful single-port robotic-assisted partial nephrectomy (SP-RAPN). This study is a retrospective review of sequential SP-RAPN cases between 7/2019 and 3/2020. We extracted patient characteristics and early surgical outcomes. Surgical tips and tricks were recorded during these cases and compiled. SP-RAPN was successfully completed in 12 patients. Patients mean age was 57.8 ± 11.0 years and median ASA score was 2. Mean tumor size was 3.1 ± 2.2 cm. The average OR Time was 172 ± 41 min and EBL was 68 ± 75 mL. All cases had warm ischemia time < 25 min. Tumor pathology included 8 RCC (6 pT1a, 1 pT1b, 1 pT2a), 2 AML, and 2 oncocytoma. There were no complications. Our top surgical tips involved: (1) patient positioning, (2) port placement, (3) insufflation, (4) air docking, (5) assistant port placement, (6) dynamic arm control, (7) hilar clamping, (8) camera relocation, (9) tumor excision, and (10) extraction and port closure. SP-RAPN is safe and feasible in this series. There are advantages and disadvantages to this platform. As the technology matures and techniques evolve, SP-RAPN may become more appealing. Future studies should focus on long-term outcomes and cost-effectiveness of the SP system.
Indexed as
Identifiers
32564222What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.